GlassScriptPhysician profile
Joann Dutko
NPI 1053486654
$1,766.83
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $588 · 2022: $338 · 2023: $494 · 2024: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $841.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $349.05 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $290.39 | 2021-2024 | Mounjaro, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $265.49 | 2021-2024 | Jardiance, Tradjenta |
| Pfizer INC. | $232.64 | 2021-2024 | |
| Novo Nordisk INC | $208.86 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Exact Sciences Corporation | $73.10 | 2023-2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $69.58 | 2021-2024 | Farxiga, Breztri |
| Sanofi-Aventis U.S. LLC | $69.28 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $60.57 | 2022-2023 | Vaxneuvance, Gardasil 9, Vaxelis |
| Nestle Healthcare Nutrition INC. | $53.76 | 2021-2023 | |
| Philips North America LLC | $23.70 | 2024 | (Ak6) Vest Therapy |
| Abbvie INC. | $22.68 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $20.51 | 2023 | Rexulti |
| Aimmune Therapeutics, INC. | $14.35 | 2024 | |
| Sanofi Pasteur INC. | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joann Dutko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.